BG100016A - Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин - Google Patents

Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин

Info

Publication number
BG100016A
BG100016A BG100016A BG10001695A BG100016A BG 100016 A BG100016 A BG 100016A BG 100016 A BG100016 A BG 100016A BG 10001695 A BG10001695 A BG 10001695A BG 100016 A BG100016 A BG 100016A
Authority
BG
Bulgaria
Prior art keywords
treatment
compounds
aids
protease inhibitors
hiv
Prior art date
Application number
BG100016A
Other languages
English (en)
Other versions
BG62083B1 (bg
Inventor
Joseph VACCA
James Guare
Bruce Dorsey
M. Holloway
Randall Hungate
Original Assignee
M. Holloway
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M. Holloway, Merck & Co. Inc. filed Critical M. Holloway
Publication of BG100016A publication Critical patent/BG100016A/bg
Publication of BG62083B1 publication Critical patent/BG62083B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретението се отнася до фармацевтична комбинация, съдържаща съединение J със структурна формула или негова фармацевтично приемлива сол и азидотимидин, или дидеоксицитидин, илидидеоксиинозин, полезна за приготвяне на фармацевтичен състав. Съставътсе използва за предпазване или лечение на инфекция от HIV и при лечение на СПИН.
BG100016A 1993-03-31 1995-09-20 Hiv протеазни инхибитори във фармацевтични комбинации залечение на спин BG62083B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31
PCT/US1994/003209 WO1994022480A1 (en) 1993-03-31 1994-03-24 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids

Publications (2)

Publication Number Publication Date
BG100016A true BG100016A (bg) 1996-04-30
BG62083B1 BG62083B1 (bg) 1999-02-26

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100016A BG62083B1 (bg) 1993-03-31 1995-09-20 Hiv протеазни инхибитори във фармацевтични комбинации залечение на спин

Country Status (34)

Country Link
EP (1) EP0617968B1 (bg)
JP (1) JPH08508496A (bg)
KR (1) KR100311551B1 (bg)
CN (1) CN1090186C (bg)
AT (1) ATE230610T1 (bg)
AU (1) AU685772B2 (bg)
BG (1) BG62083B1 (bg)
BR (1) BR9406503A (bg)
CA (1) CA2120192A1 (bg)
CY (1) CY2326B1 (bg)
CZ (1) CZ286412B6 (bg)
DE (1) DE69431972T2 (bg)
DK (1) DK0617968T3 (bg)
DZ (1) DZ1766A1 (bg)
ES (1) ES2188604T3 (bg)
FI (1) FI954580A0 (bg)
HR (1) HRP940209B1 (bg)
HU (1) HUT74006A (bg)
IL (1) IL109166A (bg)
LV (1) LV13141B (bg)
NO (1) NO953876L (bg)
NZ (1) NZ265164A (bg)
PL (1) PL310895A1 (bg)
PT (1) PT617968E (bg)
RO (1) RO118000B1 (bg)
RU (1) RU2139052C1 (bg)
SA (1) SA94140745B1 (bg)
SG (1) SG64366A1 (bg)
SI (1) SI9420017B (bg)
SK (1) SK279471B6 (bg)
TW (1) TW307684B (bg)
WO (1) WO1994022480A1 (bg)
YU (1) YU49275B (bg)
ZA (1) ZA942255B (bg)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3000564B2 (ja) * 1993-12-15 2000-01-17 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
JPH10507917A (ja) * 1994-10-25 1998-08-04 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤の微生物合成
US6689761B1 (en) * 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1095022A1 (en) 1998-07-08 2001-05-02 G.D. Searle & Co. Retroviral protease inhibitors
WO2000021565A1 (en) * 1998-10-13 2000-04-20 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019831A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019832A1 (en) 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
RU2281297C2 (ru) * 2004-08-23 2006-08-10 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского Российской академии медицинских наук Полианионные производные норборнана, способ получения и ингибиторы репродукции вируса иммунодефицита человека на их основе
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
FI922044A0 (fi) * 1990-09-11 1992-05-06 Seikagaku Kogyo Co Ltd Ny polypeptid och daerav framstaelld hiv-medicin.
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
JPH06508146A (ja) * 1991-06-04 1994-09-14 スミスクライン・ビーチャム・コーポレイション 炭素環および複素環式ｈｉｖプロテアーゼ抑制剤

Also Published As

Publication number Publication date
WO1994022480A1 (en) 1994-10-13
CA2120192A1 (en) 1994-10-01
EP0617968A1 (en) 1994-10-05
KR960701661A (ko) 1996-03-28
NZ265164A (en) 1997-09-22
DE69431972T2 (de) 2003-08-28
FI954580A7 (fi) 1995-09-27
IL109166A (en) 1999-08-17
HUT74006A (en) 1996-10-28
FI954580L (fi) 1995-09-27
SI9420017A (en) 1996-10-31
DZ1766A1 (fr) 2002-02-17
RU2139052C1 (ru) 1999-10-10
CN1120316A (zh) 1996-04-10
CZ252895A3 (en) 1996-07-17
CZ286412B6 (en) 2000-04-12
LV13141B (en) 2004-08-20
YU49275B (sh) 2005-03-15
HU9502860D0 (en) 1995-11-28
FI954580A0 (fi) 1995-09-27
SK122595A3 (en) 1997-03-05
BR9406503A (pt) 1996-01-02
CY2326B1 (en) 2003-11-14
EP0617968B1 (en) 2003-01-08
KR100311551B1 (ko) 2001-12-28
AU5921394A (en) 1994-10-06
IL109166A0 (en) 1994-06-24
TW307684B (bg) 1997-06-11
RO118000B1 (ro) 2002-12-30
HRP940209B1 (en) 2004-04-30
SK279471B6 (sk) 1998-11-04
DE69431972D1 (de) 2003-02-13
HRP940209A2 (en) 1998-02-28
PL310895A1 (en) 1996-01-08
AU685772B2 (en) 1998-01-29
ATE230610T1 (de) 2003-01-15
DK0617968T3 (da) 2003-02-24
ES2188604T3 (es) 2003-07-01
NO953876L (no) 1995-11-30
CN1090186C (zh) 2002-09-04
SG64366A1 (en) 1999-04-27
YU15994A (sh) 1999-06-15
ZA942255B (en) 1994-11-01
JPH08508496A (ja) 1996-09-10
HK1009248A1 (en) 1999-05-28
SI9420017B (sl) 2003-12-31
BG62083B1 (bg) 1999-02-26
SA94140745B1 (ar) 2006-07-11
PT617968E (pt) 2003-03-31
NO953876D0 (no) 1995-09-29

Similar Documents

Publication Publication Date Title
BG100016A (bg) Нiv протеазни инхибитори във фармацевтични комбинации за лечение на спин
RU94027563A (ru) Соединения-ингибиторы вич протеазы, их использование для лечения спида, форикомпозиция
CA2195027A1 (en) HIV Protease Inhibitors Useful for the Treatment of AIDS
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
DK0532595T3 (da) Farmakologisk anvendelse af visse cystinderivater
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
ATE253359T1 (de) Antithrombotische mittel
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
ATE286395T1 (de) Antithrombotische mittel
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
SG48115A1 (en) Inhibition of retrovirus infection
DE69824410D1 (en) Antithrombosemittel
YU231590A (sh) Derivati aminokiselina